|
Index of reports
> Cases with Hypotension (108)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include hypotension. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 108 Next >>
Possible Velcade side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Hypotension
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalidomide
Dosage: 50 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-08-06
End date: 2012-08-09
Velcade
Dosage: 1 mg/m2, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-08-06
End date: 2012-08-09
Other drugs received by patient: Dexamethasone
Possible Velcade side effects in
Reported by a physician from France on 2012-08-23
Patient:
Reactions: Back Pain, Electrocardiogram QT Prolonged, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Acetaminophen; Zelitrex / 01269701 /; Fentanyl; Atracurium Besylate; Kardegic / 00002703 /; Oxycontin; Oxygen; Tranxene; Primperan / 00041901 /; Bumetanide; Crestor; Primperan / 00041901 /; Hydrocortisone; Ondansetron; Ondansetron; Ondansetron; Importal; Tramadol HCL; Noradrenaline / 00127501 /; Tramadol HCL; Morphine; Furosemide; Midazolam; Tramadol HCL
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient: male, weighing 86.2 kg (189.6 pounds)
Reactions: Vomiting, Nausea, Hypotension, Systemic Inflammatory Response Syndrome, Pyrexia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in female
Reported by a physician from United States on 2012-08-20
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Hyperpyrexia, Anaphylactic Reaction, Chills, Pain, Hepatic Failure, Transaminases Increased, Splenic Infarction, Loss of Consciousness, Aortic Thrombosis, Off Label Use, Malaise, C-Reactive Protein Increased, Myositis, Dyspnoea, Hypotension, Arrhythmia, Lung Consolidation, Hypophosphataemia, Zygomycosis, Bacteraemia, Ventricular Tachycardia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Cytarabine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Decadron Phosphate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
Doxil
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate
Dosage: day 1
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
PEG-Asparaginase
Dosage: day 2, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
End date: 2007-10-25
Velcade
Dosage: day 1, 4, 8 and 11
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: day 1,8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Velcade side effects in 14 year old male
Reported by a physician from United States on 2012-08-20
Patient: 14 year old male, weighing 71.4 kg (157.1 pounds)
Reactions: Dyspnoea, Hypotension, Sepsis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-10
Cytarabine
Dosage: 70 mg, cyclic
Start date: 2012-08-09
End date: 2012-08-09
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-08-09
End date: 2012-08-09
Possible Velcade side effects in
Reported by a physician from France on 2012-08-16
Patient:
Reactions: Electrocardiogram QT Prolonged, Back Pain, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Other drugs received by patient: Ceftriaxone; Primperan / 00041901 /; Bumetanide; Acetaminophen; Morphine; Atracurium Besylate; Ondansetron; Crestor; Fentanyl; Furosemide; Midazolam; Tranxene; Ondansetron; Tramadol HCL; Noradrenaline / 00127501 /; Hydrocortisone; Importal; Tramadol HCL; Kardegic / 00002703 /; Primperan / 00041901 /; Primperan / 00041901 /; Tramadol HCL; Zelitrex / 01269701 /; Oxycontin; Oxygen; Ondansetron
Possible Velcade side effects in female
Reported by a physician from United States on 2012-08-14
Patient: female, weighing 70.8 kg (155.8 pounds)
Reactions: Abdominal Pain, Rhabdomyolysis, Hyperpyrexia, Chills, Anaphylactic Reaction, Bone Pain, Hepatic Failure, Transaminases Increased, Loss of Consciousness, Aortic Thrombosis, Splenic Infarction, Hypokalaemia, Malaise, C-Reactive Protein Increased, Dyspnoea, Hypotension, Hypophosphataemia, Zygomycosis, Bacteraemia, Hyperammonaemia, Neutropenia, Hepatic Infarction, Lung Infiltration, Shock, Infusion Related Reaction
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-10-23
Decadron Phosphate
Dosage: 9 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Methotrexate Sodium
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2005-01-01
End date: 2007-01-01
Pegaspargase
Dosage: unk, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-25
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Vincristine
Dosage: 2 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2007-10-23
End date: 2007-10-23
Possible Velcade side effects in female
Reported by a physician from United States on 2012-08-10
Patient: female, weighing 62.0 kg (136.4 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Pneumonia Fungal, Dyspnoea, Hypotension, Muscular Weakness, Febrile Neutropenia, Hypokalaemia, Dehydration, Hypoxia, Pulmonary Oedema, Hypoalbuminaemia, Neutrophil Count Decreased, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decitabine
Dosage: 20 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-27
End date: 2012-05-06
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-27
End date: 2012-05-06
Possible Velcade side effects in male
Reported by a physician from United States on 2012-08-09
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Abdominal Pain, Atelectasis, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Activated Partial Thromboplastin Time Prolonged, Multi-Organ Failure, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Alanine Aminotransferase Increased, Hypotension, Hypercalcaemia, Respiratory Failure, Embolism, Cardiac Failure, Aspartate Aminotransferase Increased, Ventricular Tachycardia, Ejection Fraction Decreased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 100 mg/kg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Daunorubicin HCL
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Velcade side effects in
Reported by a physician from United Kingdom on 2012-08-08
Patient:
Reactions: Hypotension, Autonomic Neuropathy, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Zimovane; Difene; Oxycontin; Allopurinol
Possible Velcade side effects in
Reported by a physician from United Kingdom on 2012-07-27
Patient:
Reactions: Pneumocystis Jiroveci Pneumonia, Neutropenic Sepsis, Hypotension, Dehydration, Pulmonary Oedema, Psittacosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1600 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2008-05-30
Doxorubicin Hydrochloride
Dosage: 105 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2008-05-30
Prednisone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Mantle Cell Lymphoma
Start date: 2008-05-30
Velcade
Dosage: 3.3 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2008-05-30
End date: 2008-09-03
Vincristine
Dosage: 2 mg, unk
Indication: Mantle Cell Lymphoma
Start date: 2008-05-30
Other drugs received by patient: Oramorph SR; Acyclovir; Enoxaparin Sodium; Acyclovir; Acetaminophen; Amitriptyline Hydrochloride; Gabapentin
Possible Velcade side effects in 17 year old male
Reported by a physician from United States on 2012-07-26
Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)
Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Pulmonary Oedema, Acute Respiratory Distress Syndrome
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 1000 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-27
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Daunorubicin Hydrochloride
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-26
Possible Velcade side effects in male
Reported by a physician from United States on 2012-07-24
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Atelectasis, Abdominal Pain, Disseminated Intravascular Coagulation, Acidosis, Pericardial Effusion, Multi-Organ Failure, Activated Partial Thromboplastin Time Prolonged, Left Ventricular Dysfunction, Pulmonary Oedema, Mediastinal Haemorrhage, Blood Creatinine Increased, Renal Failure Acute, Dyspnoea, Angina Pectoris, Hypotension, Alanine Aminotransferase Increased, Hypercalcaemia, Embolism, Cardiac Failure, Respiratory Failure, Ventricular Tachycardia, Ejection Fraction Decreased, Aspartate Aminotransferase Increased, Hypoalbuminaemia, Ventricular Fibrillation, Sinus Tachycardia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Cytarabine
Dosage: 100 mg/kg, bid
Start date: 2012-06-01
End date: 2012-06-03
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-21
Patient: male, weighing 87.7 kg (192.9 pounds)
Reactions: Pneumonia, Haemoptysis, Hypotension, Hyponatraemia, Fall, Dehydration, Dizziness, Hypocalcaemia, Asthenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 mg, 1/week
Indication: Multiple Myeloma
Start date: 2011-05-17
Zometa
Dosage: 2 mg, unk
Indication: Bone Loss
Start date: 2011-05-13
Other drugs received by patient: Decadron; Vicodin; Coumadin; Dulcolax; Fentanyl; Polyethylene Glycol; Fleet Enema / 00103901 /; Digoxin; Dexamethasone
Possible Velcade side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient: male, weighing 31.8 kg (70.0 pounds)
Reactions: Abdominal Pain, Acidosis, Pericardial Effusion, Left Ventricular Dysfunction, Hypocalcaemia, Renal Failure Acute, Pneumonitis, Dyspnoea, Angina Pectoris, Hypotension, Anaemia, Delirium, Tumour Lysis Syndrome, Respiratory Failure, Cardiac Failure, Aspartate Aminotransferase Increased, Ejection Fraction Decreased, Sinus Tachycardia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Ativan
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 100 mg/kg, bid
Start date: 2012-06-01
End date: 2012-06-03
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-11
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-05
Fentanyl
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-01
End date: 2012-06-01
Possible Velcade side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-16
Patient: female, weighing 59.0 kg (129.7 pounds)
Reactions: Vomiting, Fatigue, Nausea, Oesophagitis, Dehydration, Urinary Tract Infection, Hypotension, Systemic Inflammatory Response Syndrome, Lobar Pneumonia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Prilosec; Colace; Prozac; Fentanyl; Potassium Chloride; Vicodin; Iron; Atenolol; Synthroid; Warfarin Sodium
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16
Patient: male, weighing 86.2 kg (189.6 pounds)
Reactions: Vomiting, Nausea, Hypotension, Systemic Inflammatory Response Syndrome, Pyrexia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Start date: 2012-04-17
End date: 2012-04-24
Velcade
Dosage: 2.3 mg, unk
Start date: 2012-05-04
Possible Velcade side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Off Label Use, Dyspnoea, Hypotension, Chest Pain, Pleural Effusion, Troponin Increased, Pyrexia, Myocardial Infarction
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Bendroflumethiazide; Codeine Sulfate; Dexamethasone; Gabapentin; Ibuprofen; Bisacodyl; Acetaminophen; Pamidronate Disodium; Amitriptyline HCL; Diazepam; Enoxaparin; Tramadol HCL
Possible Velcade side effects in
Reported by a physician from Ireland on 2012-07-09
Patient:
Reactions: Hypotension, Autonomic Neuropathy, Fall
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Difene; Allopurinol; Oxycontin; Zimovane
Possible Velcade side effects in 17 year old male
Reported by a physician from United States on 2012-07-09
Patient: 17 year old male, weighing 84.1 kg (185.0 pounds)
Reactions: Hypotension, Pyrexia, Left Ventricular Dysfunction, Restrictive Cardiomyopathy, Cardiac Failure, Sepsis, Acute Respiratory Distress Syndrome, Pulmonary Oedema
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 100 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Cytarabine
Dosage: 1000 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-27
Daunorubicin Hydrochloride
Dosage: 50 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Daunorubicin Hydrochloride
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-23
Etoposide
Dosage: 150 mg/m2, cyclic
Start date: 2012-05-18
End date: 2012-06-23
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-18
End date: 2012-06-26
Possible Velcade side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-06
Patient:
Reactions: Death, Dehydration, Hypotension, Mental Status Changes, Clostridial Infection, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Revlimid
Administration route: Oral
Velcade
Possible Velcade side effects in 76 year old male
Reported by a physician from Japan on 2012-07-03
Patient: 76 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Off Label Use, C-Reactive Protein Increased, Interstitial Lung Disease, Hypotension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Levofloxacin
Indication: C-Reactive Protein Increased
Start date: 2012-04-16
Levofloxacin
Start date: 2012-06-04
Velcade
Start date: 2012-05-14
End date: 2012-06-04
Velcade
Indication: Multiple Myeloma
Start date: 2012-03-27
End date: 2012-04-17
Velcade
Start date: 2012-03-06
End date: 2012-03-16
Other drugs received by patient: Decadron; Decadron; Decadron
Possible Velcade side effects in
Reported by a physician from Serbia on 2012-06-29
Patient:
Reactions: Malaise, Hyperpyrexia, Hypoproteinaemia, Diarrhoea, Hypotension, Pseudomembranous Colitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Adriablastin
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-11-23
End date: 2012-03-01
Amikacin
Dexamethasone
Dosage: unk
Indication: Multiple Myeloma
Start date: 2011-11-23
End date: 2012-03-01
Meropenem
Vancomycin
Velcade
Dosage: 1.3 mg, unk
Indication: Multiple Myeloma
End date: 2012-03-01
Other drugs received by patient: Diunorm; Losartan Potassium; Norvasc; Pantoprazole
Possible Velcade side effects in male
Reported by a pharmacist from United States on 2012-06-29
Patient: male, weighing 21.3 kg (46.9 pounds)
Reactions: B-Cell Lymphoma, Hypotension, Alanine Aminotransferase Increased, Pancytopenia, Roseolovirus Test Positive, Aspartate Aminotransferase Increased, Venoocclusive Liver Disease, Acute Respiratory Distress Syndrome, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Product Used FOR Unknown Indication
Fludarabine Phosphate
Indication: Product Used FOR Unknown Indication
Mesna
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B-Cell Lymphoma
Start date: 2011-12-27
End date: 2012-01-16
Possible Velcade side effects in 76 year old male
Reported by a physician from Japan on 2012-06-28
Patient: 76 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Off Label Use, Lung Disorder, C-Reactive Protein Increased, Hypotension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Levofloxacin
Start date: 2012-06-04
Levofloxacin
Indication: C-Reactive Protein Increased
Start date: 2012-04-16
Velcade
Start date: 2012-05-14
End date: 2012-06-04
Velcade
Start date: 2012-03-06
End date: 2012-03-16
Velcade
Indication: Multiple Myeloma
Start date: 2012-03-27
End date: 2012-04-17
Other drugs received by patient: Decadron; Decadron; Decadron
Possible Velcade side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28
Patient: 65 year old female, weighing 78.9 kg (173.6 pounds)
Reactions: Hypotension, Anaemia, Electrolyte Imbalance, Thrombocytopenia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-01
End date: 2012-06-18
Velcade
Dosage: 1 milligram
Indication: Multiple Myeloma
Start date: 2011-11-30
End date: 2012-04-30
Possible Velcade side effects in 62 year old female
Reported by a physician from United States on 2012-06-27
Patient: 62 year old female, weighing 62.0 kg (136.4 pounds)
Reactions: Pneumonia Fungal, Blood Alkaline Phosphatase Increased, Dyspnoea, Hypotension, Febrile Neutropenia, Muscular Weakness, Hypokalaemia, Dehydration, Hypoxia, Hypoalbuminaemia, Pulmonary Oedema, Neutrophil Count Decreased, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decitabine
Dosage: 20 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-27
End date: 2012-05-06
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-27
End date: 2012-05-06
Possible Velcade side effects in 72 year old female
Reported by a consumer/non-health professional from United States on 2012-06-21
Patient: 72 year old female, weighing 59.0 kg (129.7 pounds)
Reactions: Vomiting, Fatigue, Nausea, Urinary Tract Infection, Dehydration, Hypotension, Systemic Inflammatory Response Syndrome, Lobar Pneumonia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Possible Velcade side effects in male
Reported by a individual with unspecified qualification from France on 2012-06-18
Patient: male
Reactions: Diarrhoea, Anaemia, Hypotension, Leukaemia Plasmacytic, Paraesthesia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2011-08-29
End date: 2011-12-30
Velcade
Start date: 2011-08-29
End date: 2011-12-30
Other drugs received by patient: Levothyroxine Sodium; Atacand; Nicardipine Hydrochloride
Possible Velcade side effects in
Reported by a physician from France on 2012-06-18
Patient:
Reactions: Electrocardiogram QT Prolonged, Back Pain, Death, Dyspnoea, Hypotension, Thrombocytopenia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
JNJ-26481585
Dosage: 12 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-21
End date: 2012-05-31
Velcade
Dosage: 2.1 mg, unk
Indication: Multiple Myeloma
Start date: 2012-05-22
End date: 2012-05-29
Page 1 Next >>
|
